Quarterly Transactions Made in Akebia Therapeutics, Inc. (AKBA)
This table provides information about the institutional ownership of Akebia Therapeutics, Inc. (AKBA). The information is specifically focused on institutions that hold shares of Akebia Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q2 2021 | 5,737,675 | 30,001,551 | 35,739,226 | 7,153,084 | 1,736,195 | 8,889,279 | 26,849,947 | |
| Q3 2021 | 11,605,596 | 8,311,969 | 19,917,565 | 4,036,083 | 11,626,324 | 15,662,407 | 4,255,158 | |
| Q4 2021 | 5,503,395 | 4,033,793 | 9,537,188 | 9,059,041 | 1,534,345 | 10,593,386 | -1,056,198 | |
| Q1 2022 | 4,860,485 | 1,253,365 | 6,113,850 | 6,900,471 | 8,893,820 | 15,794,291 | -9,680,441 | |
| Q2 2022 | 8,164,641 | 10,226,822 | 18,391,463 | 35,800,508 | 5,891,711 | 41,692,219 | -23,300,756 | |
| Q3 2022 | 4,217,637 | 1,754,229 | 5,971,866 | 9,368,267 | 37,402 | 9,405,669 | -3,433,803 | |
| Q4 2022 | 11,142,088 | 278,590 | 11,420,678 | 9,082,141 | 1 | 9,082,142 | 2,338,536 | |
| Q1 2023 | 3,588,645 | 525,264 | 4,113,909 | 3,251,985 | 0 | 3,251,985 | 861,924 | |
| Q2 2023 | 3,159,320 | 1,324,358 | 4,483,678 | 5,819,661 | 0 | 5,819,661 | -1,335,983 | |
| Q3 2023 | 1,280,136 | 214,772 | 1,494,908 | 1,916,261 | 0 | 1,916,261 | -421,353 | |
| Q4 2023 | 5,607,468 | 800,687 | 6,408,155 | 1,593,636 | 0 | 1,593,636 | 4,814,519 | |
| Q1 2024 | 6,478,310 | 4,163,928 | 10,642,238 | 7,438,248 | 0 | 7,438,248 | 3,203,990 | |
| Q2 2024 | 17,232,089 | 1,081,350 | 18,313,439 | 17,641,919 | 0 | 17,641,919 | 671,520 | |